CARA Price Targets and Analyst Ratings NASDAQ:CARA
CARA Forecast. What You Should Know.
CARA Historical Ratings and Targets
About Cara Therapeutics
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of mod... CARA Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.